These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

683 related articles for article (PubMed ID: 28669745)

  • 1. The role of mitochondria in amyotrophic lateral sclerosis.
    Smith EF; Shaw PJ; De Vos KJ
    Neurosci Lett; 2019 Sep; 710():132933. PubMed ID: 28669745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current Concepts on Genetic Aspects of Mitochondrial Dysfunction in Amyotrophic Lateral Sclerosis.
    Jankovic M; Novakovic I; Gamil Anwar Dawod P; Gamil Anwar Dawod A; Drinic A; Abdel Motaleb FI; Ducic S; Nikolic D
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Link between Oxidative Stress, Redox Status, Bioenergetics and Mitochondria in the Pathophysiology of ALS.
    Obrador E; Salvador-Palmer R; López-Blanch R; Jihad-Jebbar A; Vallés SL; Estrela JM
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34198557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial dysfunction is a converging point of multiple pathological pathways in amyotrophic lateral sclerosis.
    Shi P; Wei Y; Zhang J; Gal J; Zhu H
    J Alzheimers Dis; 2010; 20 Suppl 2():S311-24. PubMed ID: 20463400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial Dyshomeostasis as an Early Hallmark and a Therapeutic Target in Amyotrophic Lateral Sclerosis.
    Belosludtseva NV; Matveeva LA; Belosludtsev KN
    Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial disfunction as a cause of ALS.
    Pizzuti A; Petrucci S
    Arch Ital Biol; 2011 Mar; 149(1):113-9. PubMed ID: 21412720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial dysfunction in amyotrophic lateral sclerosis - a valid pharmacological target?
    Muyderman H; Chen T
    Br J Pharmacol; 2014 Apr; 171(8):2191-205. PubMed ID: 24148000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial dysfunction and amyotrophic lateral sclerosis.
    Hervias I; Beal MF; Manfredi G
    Muscle Nerve; 2006 May; 33(5):598-608. PubMed ID: 16372325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondria in amyotrophic lateral sclerosis: a trigger and a target.
    Dupuis L; Gonzalez de Aguilar JL; Oudart H; de Tapia M; Barbeito L; Loeffler JP
    Neurodegener Dis; 2004; 1(6):245-54. PubMed ID: 16908975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial dysfunction in amyotrophic lateral sclerosis.
    Shi P; Gal J; Kwinter DM; Liu X; Zhu H
    Biochim Biophys Acta; 2010 Jan; 1802(1):45-51. PubMed ID: 19715760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial dysfunction in ALS.
    Cozzolino M; Carrì MT
    Prog Neurobiol; 2012 May; 97(2):54-66. PubMed ID: 21827820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancing mitochondrial calcium buffering capacity reduces aggregation of misfolded SOD1 and motor neuron cell death without extending survival in mouse models of inherited amyotrophic lateral sclerosis.
    Parone PA; Da Cruz S; Han JS; McAlonis-Downes M; Vetto AP; Lee SK; Tseng E; Cleveland DW
    J Neurosci; 2013 Mar; 33(11):4657-71. PubMed ID: 23486940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial involvement in amyotrophic lateral sclerosis.
    Menzies FM; Ince PG; Shaw PJ
    Neurochem Int; 2002 May; 40(6):543-51. PubMed ID: 11850111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial dysfunction and intracellular calcium dysregulation in ALS.
    Kawamata H; Manfredi G
    Mech Ageing Dev; 2010; 131(7-8):517-26. PubMed ID: 20493207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the Mitochondrial Aerobic Metabolism in the Pre- and Perisynaptic Districts of the SOD1
    Ravera S; Bonifacino T; Bartolucci M; Milanese M; Gallia E; Provenzano F; Cortese K; Panfoli I; Bonanno G
    Mol Neurobiol; 2018 Dec; 55(12):9220-9233. PubMed ID: 29656361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review: The role of mitochondria in the pathogenesis of amyotrophic lateral sclerosis.
    Duffy LM; Chapman AL; Shaw PJ; Grierson AJ
    Neuropathol Appl Neurobiol; 2011 Jun; 37(4):336-52. PubMed ID: 21299590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring new pathways of neurodegeneration in ALS: the role of mitochondria quality control.
    Palomo GM; Manfredi G
    Brain Res; 2015 May; 1607():36-46. PubMed ID: 25301687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial involvement in amyotrophic lateral sclerosis: trigger or target?
    Bacman SR; Bradley WG; Moraes CT
    Mol Neurobiol; 2006 Apr; 33(2):113-31. PubMed ID: 16603792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondria: A Promising Convergent Target for the Treatment of Amyotrophic Lateral Sclerosis.
    Cunha-Oliveira T; Montezinho L; Simões RF; Carvalho M; Ferreiro E; Silva FSG
    Cells; 2024 Jan; 13(3):. PubMed ID: 38334639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Swim Training Modulates Mouse Skeletal Muscle Energy Metabolism and Ameliorates Reduction in Grip Strength in a Mouse Model of Amyotrophic Lateral Sclerosis.
    Flis DJ; Dzik K; Kaczor JJ; Cieminski K; Halon-Golabek M; Antosiewicz J; Wieckowski MR; Ziolkowski W
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30634386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.